Translocated in liposarcoma (TLS) is a substrate for fibroblast growth factor receptor-1

Peter Klint1, Ulf Hellman, Christer Wernstedt

  • 1Rudbeck Laboratory, Department of Genetics and Pathology, 751 85, Uppsala, Sweden.

Cellular Signalling
|January 8, 2004
PubMed

Insights

Fibroblast growth factor receptor-1 (FGFR-1) phosphorylates translocated in liposarcoma (TLS). This RNA/DNA-binding protein is implicated in growth regulation and cancer, suggesting a new role for FGFR-1 signaling in tumor development.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • Fibroblast growth factor (FGF) binding to fibroblast growth factor receptor-1 (FGFR-1) activates its tyrosine kinase activity.
  • Several FGFR-1 substrates, including FGF receptor-substrate-2 (FRS-2), are known.
  • FRS-2 was identified via interaction with yeast protein p13suc, involved in cell cycle regulation.

Purpose of the Study:

  • To identify novel substrates of FGFR-1 kinase activity.
  • To investigate the role of the translocated in liposarcoma (TLS) protein in growth regulation.

Main Methods:

  • Utilized immobilized p13suc to screen for interacting proteins.
  • Performed tyrosine phosphorylation assays in intact cells stimulated with growth factors.

Main Results:

  • Identified "translocated in liposarcoma" (TLS) as a novel substrate for FGFR-1.
  • TLS, an RNA/DNA-binding protein found in tumor-associated fusion products, is tyrosine phosphorylated by multiple growth factors.
  • Demonstrated TLS tyrosine phosphorylation in intact cells.

Conclusions:

  • TLS is a direct substrate of FGFR-1 kinase.
  • TLS tyrosine phosphorylation by growth factors suggests its involvement in cellular growth regulation.
  • These findings highlight a potential role for TLS in growth factor-mediated signaling pathways relevant to cancer.